Efforts to improve the anti-tumor effect of gemcitabine in human pancreatic cancer

被引：0

作者：

Nakamori, Shoji ^{[1
]}

Kashiwazaki, Masaki ^{[1
]}

Ikenaga, Masakazu ^{[1
]}

Miyazaki, Michihiko ^{[1
]}

Hirao, Motohiro ^{[1
]}

Fujitani, Kazumasa ^{[1
]}

Mishima, Hideyuki ^{[1
]}

Tsujinaka, Toshimasa ^{[1
]}

Nakahira, Shin ^{[2
]}

Tsujie, Masanori ^{[2
]}

Takeda, Yutaka ^{[2
]}

Monden, Morito ^{[2
]}

机构：

[1] Osaka Natl Hosp, Dept Surg, Osaka, Japan

[2] Osaka Univ, Grad Sch, Dept Gastrointestinal Surg, Suita, Osaka 565, Japan

来源：

PANCREAS | 2008年 / 37卷 / 01期

关键词：

D O I：

10.1097/01.mpa.0000325600.76722.6d

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：111 / 112

页数：2

共 50 条

[21] Reactivity of novel rat mAbs with human pancreatic cancer tissues and anti-tumor effects on pancreatic cancer cells
Yoshimoto, Soshi
Hayashi, Natsumi
Okita, Kouki
Yagi, Hideki
Ishiwata, Toshiyuki
Masuko, Takashi
Endo, Yuichi
Sugiura, Reiko
CANCER SCIENCE, 2021, 112 : 745 - 745
[22] Anti-tumor effect of dendritic cell-based immunotherapy in combination with gemcitabine/S-1 in the patients with advanced pancreatic cancer
Okamoto, Masato
CANCER RESEARCH, 2009, 69
[23] ANTI-TUMOR EFFECT OF LAPATINIB PLUS S-1 AGAINST PANCREATIC CANCER
Nakata, Bunzo
Komoto, Masahiro
Takashima, Tsutomu
Amano, Ryosuke
Yamada, Nobuya
Nakano, Taeko
Yashiro, Masakazu
Hirakawa, Kosei
ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
[24] Anti-tumor activity of Apo2L/TRAIL in combination with gemcitabine against human pancreatic carcinoma xenografts
Bush, Tammy
de Vries, Anne Renee Van der Vuurst
Belmontes, Brian
Ziegler, Beth
Branstetter, Daniel
Radinsky, Robert
Holland, Pamela M.
CANCER RESEARCH, 2006, 66 (08)
[25] Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system
Yu, Wei-Dong
Ma, Yingyu
Flynn, Geraldine
Muindi, Josephia R.
Kong, Rui-Xian
Trump, Donald L.
Johnson, Candace S.
CELL CYCLE, 2010, 9 (15) : 3022 - 3029
[26] ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer
Wu, Yinfang
Mou, Xiaozhou
Wang, Shibing
Liu, Xing-E
Sun, Xiaodong
ONCOTARGET, 2017, 8 (47) : 82728 - 82739
[27] Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
Eun-Kyoung Koh
Hong-Rae Lee
Woo-Chang Son
Ga-Young Park
Juhee Kim
Jae-Ho Bae
You-Soo Park
Scientific Reports, 13
[28] Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape
Lee, Ji Eun
Kang, Yeo Wool
Jung, Kyung Hee
Son, Mi Kwon
Shin, Seung-Min
Kim, Ji-Sun
Kim, Soo Jung
Fang, Zhenghuan
Yan, Hong Hua
Park, Jung Hee
Yoon, Young-Chan
Han, Boreum
Cheon, Min Ji
Woo, Min Gyu
Seo, Myung Sung
Lim, Joo Han
Kim, Yong-Sung
Hong, Soon-Sun
CANCER LETTERS, 2021, 507 : 97 - 111
[29] Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
Koh, Eun-Kyoung
Lee, Hong-Rae
Son, Woo-Chang
Park, Ga-Young
Kim, Juhee
Bae, Jae-Ho
Park, You-Soo
SCIENTIFIC REPORTS, 2023, 13 (01)
[30] THE PROTEASE INHIBITOR GABEXATE MESYLATE HAS ANTI-TUMOR EFFECTS AND ENHANCES GEMCITABINE ACTION ON PANCREATIC CANCER CELL LINES
Brandi, Giovanni
Tavolari, Simona
Paterini, Paola
de Rosa, Francesco
Di Girolamo, Stefania
Agostini, Valentina
Di Cicilia, Roberto
Di Marco, Mariacristina
Nobili, Elisabetta
Biasco, Guido
ANNALS OF ONCOLOGY, 2009, 20

← 1 2 3 4 5 →